Evidence map›Paper›PMID 40462217›Full record

ArticleBMC psychology2025

Cognitive and emotional benefits of individual reminiscence therapy in elderly stroke survivors: study protocol for a randomized controlled study.

Shan Wang, Miaomiao Hu, Yehua Xue, Yeping Chen, Kunpeng Li, Lu Dong, Libing Liang, Jieting Jiang, Xuemin Li, Caiqin Wu

Abstract readClinical Trial Protocol
In one paragraph

Article in BMC psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shan Wang *School of Nursing, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Miaomiao Hu *School of Nursing, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Yehua Xue *School of Nursing, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Yeping ChenScientific research department, Shanghai Second Rehabilitation Hospital, Shanghai, 200940, China.
Kunpeng LiSchool of Exercise and Health, Shanghai University of Sport, Shanghai, 200438, China.
Lu DongSchool of Nursing, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Libing LiangSchool of Nursing, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Jieting JiangOncology department, Guiqian International General Hospital, Guiyang, 550024, China.
Xuemin LiRehabilitation Medicine Department, Yangpu Hospital of Tongji University, Shanghai, 200090, China. lxmryf@126.com.
Caiqin WuSchool of Nursing, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. yuwuchina@aliyun.com.

Funding

Shanghai Baoshan Science and Technology Commission 2024-E-66
6 · The paper itself

Abstract

backgroundPost-stroke cognitive impairment (PSCI) and depression affect over 60% of elderly stroke survivors, severely impairing functional recovery and quality of life. Despite the efficacy of non-pharmacological interventions, evidence on individualized approaches for elderly stroke patients remains limited. This study aims to evaluate the clinical impact of individual reminiscence therapy (RT) on cognitive function, depressive symptoms, and quality of life in elderly stroke survivors.

methodsA single-blinded, parallel, randomized controlled trial will be conducted with 80 elderly stroke patients recruited from two hospitals in Shanghai. Participants will be randomly assigned to an intervention group receiving eight weeks of individual RT (30-45 min weekly) or a control group receiving standard care with a 1:1 ratio. Cognitive function, including Mini-Mental State Examination (MMSE), Boston Naming Test (BNT), Trail Making Test-A (TMT-A), depressive symptoms assessed by the Patient Health Questionnaire-9 (PHQ-9), and quality of life assessed by the Stroke-Specific Quality of Life Scale (Ss-QoL) will be assessed by blinded evaluators at baseline (T0), post-intervention (8 weeks, T1), and 4-week follow-up (12 weeks, T2). The intervention features a tailored RT protocol allowing patients to select topics (e.g., childhood memories, work life) to enhance engagement. Blinded evaluators will ensure measurement objectivity, and intention-to-treat analysis addressed attrition. DISCUSSION: This study aims to provide a fresh perspective on the effectiveness of individual RT in enhancing cognitive function, reducing depressive symptoms, and improving the quality of life, among stroke patients. The use of a tailored individual RT program based on an in-depth literature review and conceptual analysis, along with a multidimensional assessment system, differentiates this study from previous ones.

trial registrationThis protocol was registered at the Chinese Clinical Trials.gov (Identifier: ChiCTR2500095471) on January 8, 2025.

Indexed as

Cognitive DysfunctionDepressionStrokeStroke RehabilitationAgedAged, 80 and overCognitionFemaleHumansMaleQuality of LifeRandomized Controlled Trials as TopicSingle-Blind MethodSurvivorsCognitionDepressionProtocolRandomized controlled trialReminiscence therapyStroke

Identifiers

PMID40462217
PMCPMC12135237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.